Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 5.75
+0.05 (0.88%)
At close: Oct 6, 2026
Viromed Medical AG Revenue
Viromed Medical AG had revenue of 2.55M EUR in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 5.22M, up 115.74% year-over-year. In the year 2025, Viromed Medical AG had annual revenue of 5.09M with 352.27% growth.
Revenue (ttm)
5.22M
Revenue Growth
+115.74%
P/S Ratio
23.22
Revenue / Employee
306.79K
Employees
17
Market Cap
121.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.09M | 3.96M | 352.27% |
| Dec 31, 2024 | 1.12M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Medios AG | 2.16B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| Stratec SE | 244.81M |
| LIMES Schlosskliniken AG | 56.72M |